Portfolio company
Averna Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This biotechnology company develops genomic medicines using RNA-based technology to insert therapeutic genes into safe genomic locations for patients with various diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Aera Therapeutics
This biotechnology company develops delivery platforms for genetic medicines to treat various diseases for biopharmaceutical partners and patients.
Shape Therapeutics
The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.
Aerska
This biotechnology company develops RNA interference medicines for patients with neurological disorders, using shuttle technologies to deliver therapies across the blood-brain barrier.
Orna Therapeutics
This company develops engineered circular RNA therapies and delivery systems to treat patients with cancer, autoimmune conditions, and genetic diseases.
Alia Therapeutics
The company develops gene editing medicines for patients with genetic diseases.
Typewriter Therapeutics
The company develops RNA-based genetic medicines for patients with cancer, autoimmune conditions and rare genetic diseases.
Airna
This company develops RNA editing therapeutics to treat patients with rare genetic and common cardiometabolic diseases.
Etherna
This company develops mRNA and lipid nanoparticle technologies for pharmaceutical and biotechnology partners to create nucleic acid-based medicines and vaccines.